BAT's Fit2Win Program Targets £600M Savings, Global Job Restructuring

British American Tobacco (BAT) is progressing with its Fit2Win transformation program, aiming to achieve approximately £600 million in annual cost savings by the end of 2028, as reported by Tobacco Reporter. The initiative, launched in 2025, involves simplifying operations, expanding technology partnerships, and optimizing its global manufacturing footprint. This restructuring is intended to create a more agile organization capable of responding to evolving market conditions and accelerating its transition towards reduced-risk products.

As part of the Fit2Win program, BAT plans to eliminate about 5,500 roles and transfer approximately 3,500 positions to strategic partners, impacting around 9,000 employees globally, excluding the United States, according to Reuters. The company has already transitioned selected roles to partners including Accenture, Systems Limited, and ITC Infotech. Additionally, BAT has launched a new Future Capabilities Centre in India and continues to optimize its manufacturing network, which includes the previously announced closure of its Heidelberg factory in South Africa.

BAT CEO Tadeu Marroco stated that Fit2Win is creating a “simpler, faster BAT,” emphasizing the company's support for affected employees during the transition. This restructuring aligns with BAT's ongoing efforts to adapt to declining cigarette volumes. The company is simultaneously increasing investment in next-generation products, such as Vuse e-cigarettes and Velo nicotine pouches, as part of its strategy to focus on harm reduction options.

The strategic changes under Fit2Win underscore BAT's commitment to evolving its business model in response to market shifts. By streamlining operations and enhancing technology integration, the company aims to improve efficiency and resource allocation. This focus on agility and technological enablement is crucial for navigating the complexities of the global tobacco and nicotine product markets, particularly as consumer preferences continue to shift towards modern oral nicotine products and other tobacco alternatives.